Observational studyJournal of the American Heart Association2025
Relationship Between Remnant Cholesterol and Risk of Heart Failure in a Community Population Without Cardiovascular Disease: Results of the China Patient-Centered Evaluative Assessment of Cardiac Events Million Persons Project.
Observational study in Journal of the American Heart Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Triglyceride-Rich Lipoproteins and Inflammation: Independent and Synergistic Roles in Cardiovascular Disease.Current atherosclerosis reports · 2026Review
- Association between serum total cholesterol levels and the risk of incident heart failure in patients with atherosclerotic cardiovascular disease.Frontiers in medicine · 2026Article
- Residual cholesterol inflammatory index and its prognostic role in mortality among individuals with cardiovascular-kidney-metabolic syndrome stages 0-3 based on U.S. and Chinese national cohorts.European journal of medical research · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe association between heart failure (HF) and remnant cholesterol (RC) has not been comprehensively elucidated.
methodsThis study assessed data from 90 280 individuals (mean age, 54 years; 61.2% women) in the China Patient-Centered Evaluative Assessment of Cardiac Events Million Persons Project, all free of cardiovascular disease at baseline. RC was calculated by the equation: total cholesterol minus high-density lipoprotein cholesterol minus low-density lipoprotein cholesterol (LDL-C), with low-density lipoprotein cholesterol derived using the Friedewald equation. Cox proportional hazards model was used to examine the relationship of RC to HF risk. We also assessed the correlation between left ventricular structure and function and RC levels using multivariable linear regression models in 15 004 participants with echocardiographic data.
resultsThe study had a median follow-up period of 3.52 years and recorded 1105 new-onset HF events. In multivariable models, every SD increment in RC was associated with a 7% increased risk of HF (hazard ratio [HR], 1.07 [95% CI, 1.01-1.13]), with a noted gradient of association. Even after accounting for interim myocardial infarction/coronary heart disease, individuals with high baseline RC (≥1.1 mmol/L) remained at a 24% greater HF risk (HR, 1.24 [95% CI, 1.05-1.46]) than the low group (<0.63 mmol/L). Each SD in the log-transformed baseline RC increase was significantly correlated with increases in relative wall thickness (β=0.0014;
conclusionsElevated RC is linked to unfavorable left ventricular structure and function alterations, increasing the risk of subsequent HF. This association with HF appears to be independent of interim myocardial infarction/coronary heart disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.